Stay updated on Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.

Latest updates to the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has updated the intervention type to 'Verified 2018-03 by Royal Marsden NHS Foundation Trust' with a new status of 'Recruiting' and a revision to v2.14.0, while the previous intervention type and revision v2.13.3 have been removed.SummaryDifference1%
- Check92 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.